celiprolol has been researched along with Obesity in 4 studies
Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metoprolol was without significant effect on any of these variables following chronic administration." | 5.30 | The beta2-adrenergic modulator celiprolol reduces insulin resistance in obese Zucker rats. ( Dietze, GJ; Fogt, DL; Henriksen, EJ; Jacob, S, 1999) |
| "Celiprolol did not activate lipolysis in rat adipocytes in vitro or stimulate human beta(3)-adrenoceptors expressed in Chinese hamster ovary cells as measured with Cytosensor microphysiometer." | 1.31 | Effects of chronic celiprolol treatment on brown fat, feeding, and drinking in fa/fa Zucker rats. ( Huupponen, R; Koulu, M; Luukkaa, V; Malminiemi, K; Pesonen, U; Rouru, J; Savontaus, E, 2000) |
| "Metoprolol was without significant effect on any of these variables following chronic administration." | 1.30 | The beta2-adrenergic modulator celiprolol reduces insulin resistance in obese Zucker rats. ( Dietze, GJ; Fogt, DL; Henriksen, EJ; Jacob, S, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacob, S | 1 |
| Fogt, DL | 1 |
| Dietze, GJ | 1 |
| Henriksen, EJ | 1 |
| Malminiemi, K | 2 |
| Savontaus, E | 1 |
| Rouru, J | 1 |
| Luukkaa, V | 1 |
| Pesonen, U | 1 |
| Koulu, M | 1 |
| Huupponen, R | 1 |
| Taylor, SH | 1 |
1 trial available for celiprolol and Obesity
| Article | Year |
|---|---|
Long-term celiprolol therapy lowers fasting plasma leptin levels. Celiprolol Multicenter Study Group.
Topics: Adrenergic beta-Antagonists; Celiprolol; Fasting; Female; Glucose Tolerance Test; Humans; Hyperlipid | 2000 |
3 other studies available for celiprolol and Obesity
| Article | Year |
|---|---|
The beta2-adrenergic modulator celiprolol reduces insulin resistance in obese Zucker rats.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Biological Transport, Active; Blood G | 1999 |
Effects of chronic celiprolol treatment on brown fat, feeding, and drinking in fa/fa Zucker rats.
Topics: Adipose Tissue, Brown; Adrenergic beta-Antagonists; Animals; Blood Glucose; Body Temperature Regulat | 2000 |
Efficacy of celiprolol in the elderly hypertensive patient.
Topics: Adrenergic beta-Antagonists; Aged; Blood Pressure; Cause of Death; Celiprolol; Glucose; Humans; Hype | 1991 |